IBM Expands AI Consulting in May 2026 as U.S. Healthcare AI Services Market Climbs from USD 6.4 billion in 2026 to USD 18.8 billion by 2036 at 11.4% CAGR

ROCKVILLE, MARYLAND , August 28, 2026 — The Healthcare AI Consulting Services market reached USD 5.7 billion in 2025. Demand is projected to rise from USD 6.4 billion in 2026 to USD 18.8 billion by 2036, recording an 11.4% CAGR and creating a USD 12.4 billion absolute opportunity.

Fact.MR defines the market as advisory and implementation services that help healthcare organizations plan and scale AI programs across clinical, administrative, revenue-cycle, and data workflows.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16001

Key Findings

• Artificial Intelligence Strategy Consulting is expected to hold 42.0% share of Service Offering in 2026.
• Clinical Workflow Optimization is projected to account for 39.0% share of Application in 2026.
• Hospitals are anticipated to capture 41.0% share of End User in 2026.
• Project-based Consulting is estimated to represent 47.0% share of Engagement Model in 2026.
• Generative Artificial Intelligence is forecast to hold 45.0% share of Artificial Intelligence Capability in 2026.

Shambhu Nath Jha, Senior Consultant at Fact.MR, states: “Healthcare AI consulting is shifting from broad digital strategy toward accountable deployment. Buyers want partners that can align model selection with clinical risk and workflow evidence.”

Growth Drivers

Demand is expected to rise as healthcare organizations move AI from trials into governed workflows. Key drivers include:

• Technology Innovation & R&D (High impact on CAGR, Global, 2026-2036): AI strategy and model testing raise consulting intensity; data architecture and integration advisory add depth.
• Regulatory & Policy Drivers (Medium-High impact, North America and Europe, 2026-2032): Governance work expands because clinical oversight and model-risk controls must be documented.
• End-User Industry Expansion (High impact, Asia Pacific and MEA, 2026-2036): Hospitals and payers scale AI use cases; life sciences companies and health-tech providers widen the buyer base.
• Operational & Cost Efficiency (Medium impact, Global, 2026-2036).

Opportunities with medium to medium-high impact on CAGR include generative AI workflow deployment (North America, Europe, 2026-2032), EHR and data interoperability advisory (Global, 2026-2036), payer automation and revenue-cycle redesign (USA, Canada, UK, 2026-2036), and AI governance and model-risk services (regulated markets, 2026-2036).

Supporting data points include:

• UK Department of Health and Social Care reported in April 2025 that an NHS England-funded ambient voice technology evaluation covered more than 7,000 patients across multiple care settings.
• Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT reported in September 2025 that predictive AI use for billing simplification rose by 25 percentage points and scheduling facilitation by 16 percentage points among U.S. non-federal acute care hospitals from 2023 to 2024.
• ASTP/ONC reported in February 2026 that approximately 9 in 10 U.S. hospitals enabled patient access to health information through an API in 2024, while 71% used standards-based APIs.
• UK Department of Health and Social Care and NHS England reported in October 2025 that a Microsoft 365 Copilot trial covered more than 30,000 NHS workers across 90 organizations and saved an average of 43 minutes per staff member per day.

Segment Analysis

By Service Offering

Artificial Intelligence Strategy Consulting leads at 42.0% share in 2026 because healthcare buyers need decision frameworks before choosing platforms or models. Strategy work connects board priorities with privacy rules and proof-of-value milestones. Other offerings include Implementation Advisory, Data and Integration Advisory, AI Governance Support, and Training and Change Management.

By Application

Clinical Workflow Optimization leads at 39.0% share in 2026. Hospitals target care-team efficiency through mapping of handoffs, documentation, alerting, triage, and lab workflows. Additional applications cover Administrative Automation, Revenue-cycle Operations, Patient Engagement, and Clinical Decision Support.

By End User

Hospitals lead at 41.0% share in 2026. They manage the widest range of AI-ready workflows and clinical risk under strict procurement rules. Other end users include Payers, Physician Groups, Life Sciences Companies, and Health-tech Providers.

By Engagement Model

Project-based Consulting leads at 47.0% share in 2026 due to pilot-led procurement and staged rollouts. Other models include Retained Advisory, Managed Transformation Support, Implementation Support, and Training Programs.

By Artificial Intelligence Capability

Generative Artificial Intelligence leads at 45.0% share in 2026, supporting documentation, clinical summarization, patient communication, and research review. Consulting demand focuses on prompt design and governance. Other capabilities include Machine Learning, Natural Language Processing, Predictive Analytics, and Computer Vision.

Country-Level Growth Comparison

Comparable CAGRs create different entry conditions due to procurement rules and integration barriers. Full report coverage includes North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The USA leads by 0.4 percentage points over Germany; Germany leads the UK by 0.4 points; the UK leads Canada by 0.4 points; Canada leads France by 0.5 points; France leads Japan by 0.4 points; Japan leads Australia by 0.4 points.

Competitive Landscape

Key companies include Accenture plc, Deloitte, IBM Corporation, Cognizant Technology Solutions Corporation, Infosys Limited, Capgemini SE, PwC, KPMG, EY, and Tata Consultancy Services Limited. Accenture plc, Deloitte, IBM Corporation, and Cognizant Technology Solutions Corporation have broad relevance across consulting and managed transformation services. Infosys Limited, Capgemini SE, PwC, KPMG, EY, and Tata Consultancy Services Limited extend the field through implementation and governance capabilities.

Recent Developments

• IBM expanded AI consulting capabilities in May 2026 (IBM, May 6, 2026: IBM Consulting expands AI capabilities to accelerate enterprise transformation).
• Infosys announced a Sentara collaboration in June 2026 (Infosys, June 24, 2026: Infosys collaborates with Sentara to unlock AI value and scale enterprise AI adoption in healthcare services).
• Cognizant launched TriZetto AI Gateway in August 2025 (Cognizant, August 6, 2025: Cognizant debuts TriZetto® AI Gateway to power the next generation of AI in healthcare).
• Capgemini introduced agentic AI services with NVIDIA in March 2025 (Capgemini, March 19, 2025: Capgemini accelerates enterprise adoption of agentic AI for industries with NVIDIA).
• Tata Consultancy Services was selected by NHS Supply Chain in November 2025 for a 5-year deal to transform healthcare delivery using AI & cloud (TCS, November 18, 2025).
• Accenture acquired Decho in October 2025 to scale Palantir and Gen AI capabilities across health and public service clients (Accenture, October 14, 2025).
• PwC collaborated with AWS in November 2025 to transform healthcare revenue cycle management through AI and cloud innovation (PwC, November 25, 2025).

Restraints

Growth is limited by budget pressure and fragmented data. Vendor complexity and staff capability gaps are expected to slow rollout.

• Capital Intensity & Investment (Medium impact, Developing Markets, 2026-2030): Budget limits delay consulting when hospitals must fund platform changes and staff training together.
• Supply Chain & Raw Material / Vendor complexity (Medium impact, Global, 2026-2028): Software-stack dependence slows deployment when buyers cannot align data ownership.
• Workforce & Capability Gaps (Low-Medium impact, Africa, Latin America, 2026-2036): Shortages of AI-literate clinical and technical staff lengthen implementation cycles.

How to Choose

Procurement and R&D teams evaluating Healthcare AI Consulting Services should apply these criteria drawn from market structure and buyer needs:

1.     Confirm the provider can deliver Artificial Intelligence Strategy Consulting that connects clinical priorities, data readiness, privacy rules, and proof-of-value milestones before platform selection.

2.     Require demonstrated capability in Clinical Workflow Optimization, including mapping of documentation, care coordination, triage, and handoffs that protect clinician time and patient-safety review.

3.     Verify AI governance and model-risk services that document clinical accountability, model selection, and operating controls prior to deployment.

4.     Assess experience with Generative Artificial Intelligence use cases focused on safe testing, prompt design, staff training, and integration with electronic health records and revenue-cycle systems.

5.     Prefer engagement models that support project-based pilots with staged rollouts, allowing refinement of governance before wider contracts.

6.     Evaluate country-specific expertise matching the buyer’s regulatory environment (for example, U.S. payer-provider budgets and ASTP/ONC API trends, or NHS digital programs and ambient voice evaluations).

Report Scope and Coverage

The report covers Service Offering (Artificial Intelligence Strategy Consulting, Implementation Advisory, Data and Integration Advisory, AI Governance Support, Training and Change Management), Application (Clinical Workflow Optimization, Administrative Automation, Revenue-cycle Operations, Patient Engagement, Clinical Decision Support), End User (Hospitals, Payers, Physician Groups, Life Sciences Companies, Health-tech Providers), Engagement Model, Artificial Intelligence Capability (Generative Artificial Intelligence, Machine Learning, Natural Language Processing, Predictive Analytics, Computer Vision), and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). Countries covered include USA, Germany, UK, Canada, France, Japan, and Australia. Forecast period is 2026 to 2036. The analysis draws on 120+ sources, 35+ company portfolios, 25+ countries, and more than 20 industry interviews.

Explore More Related Studies Published by Fact.MR Research

Medical and Pharmaceutical Dynamic Sealing Solutions Market- https://www.openpr.com/news/4597508/trelleborg-leads-as-usa-medical-and-pharmaceutical-dynamic

Artificial Intelligence in Hospital Operations Market- https://www.openpr.com/news/4597510/u-s-health-systems-and-microsoft-drive-ai-hospital-operations

Artificial Intelligence in Life Sciences Market- https://www.openpr.com/news/4597511/usa-ai-in-life-sciences-market-expands-as-iqvia-rolls-out-new

Medical Devices Electronic Data Interchange Market- https://www.openpr.com/news/4597525/opentext-scales-u-s-medical-device-edi-networks-as-market

Medical Device and Medtech Enterprise Resource Planning Market- https://www.openpr.com/news/4597512/sap-se-takes-15-2-share-as-u-s-medical-device-medtech-erp

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

 - Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

 Flag: The quote attributed to analyst S.N. Jha is sourced directly from published commentary on the report page and requires standard PR media sign-off before official press wire dis